Back to ARROWSTREET CAPITAL, LIMITED PARTNERSHIP ARROWSTREET CAPITAL, LIMITED PARTNERSHIP

AGIOAGIO
2 quarters

Position history for ARROWSTREET CAPITAL, LIMITED PARTNERSHIPARROWSTREET CAPITAL, LIMITED PARTNERSHIP's holdings in AGIOS PHARMACEUTICALS INC

Yes. Arrowstreet Capital holds 810,530 shares of AGIO (Agios Pharmaceuticals), worth $30.1M, as of its Q2 2026 13F filing. It increased the position from 250,461 shares in Q1 2026. Arrowstreet Capital has held AGIO since Q1 2026, across 2 quarterly 13F filings.

Current Value

$30.1M

Current Shares

810,530

Total Value Change

+$21.6M

Total Shares Change

+560,069

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
810,530
+223.6%
$30.1M0.0%$37.11
46
2026-Q1
New
250,461
-
$8.5M0.0%$33.83
38

Other major holders of AGIO: FMR LLC, WELLINGTON MANAGEMENT GROUP LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used